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Background: Changes produced in the upper airway after rapid maxillary expansion makes this procedure a the-
rapeutic option for treating sleep apnea-hypopnea syndrome (SAHS) in children. The objective of this systematic 
review and meta-analysis was to analyze the evidence available for the effects of rapid maxillary expansion (RME) 
on SAHS, analyzing changes produced in oximetric variables: apnea-hypopnea index (AHI); oxygen saturation 
(SO2); sleep efficiency (SE), total sleep time (TST), percentage of rapid eye movement (REM) phase; and arousal 
index (AI).  
Material and Methods: An electronic search was conducted in the PubMed, Scopus, Embase, and Cochrane databa-
ses, and in grey literature (Opengrey). No limit was placed on publication date or language. Inclusion criteria were: 
patients in growth with sleep apnea who underwent rapid maxillary expansion with oximetric values registered 
before and after treatment. Articles with patient sample sizes <10 were excluded. Ten articles were included for 
qualitative synthesis and nine for meta-analysis (eliminating one observational study).  
Results: AHI values underwent a mean reduction of 5.79 events/hour (CI -95% 9.06 to 2.5); an increase in mean 
oxygen saturation of 2.54 % (CI-95% -0.28 to 4.80, 6.7 %); a reduction in AI of 2.17 events/hour (CI-95% -5.25 
to -0.582); an increase in REM phase of 1.20 % (CI-95% 1.02 to 1.38); and an increase in SE of 0.961% (CI-95% 
-1.574 to 3.495).  
Conclusions. RME would appear efficient for treating slight or moderate SAHS, as indicated by improvement in 
oximetric parameters; it may be effective as coadjuvant therapy to adenotonsillectomy in severe cases of children 
with maxillary compression.
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Introduction
According to the American Academy of Sleep Medici-
ne, sleep apnea-hypopnea syndrome (SAHS) in children 
can be defined as multiple episodes in which obstruction 
of the upper airway (UA) is produced, impeding respira-
tion during sleep. SAHS produces reductions in partial 
oxygen saturation, which induces a micro-awakening to 
reestablish normal oxygen flow (1). These events inte-
rrupt the normal structure of sleep and impede its repa-
rative function (2). This can trigger excessive daytime 
sleepiness, underachievement at school, and in severe 
cases, neuropsychiatric disorders and a risk of cardio-
vascular disorders; all these problems impact on the pa-
tient’s quality of life (3).
SAHS has a prevalence of 1-10% in the pediatric po-
pulation (3), the most common cause of SAHS being 
amygdala hypertrophy, although its etiology is usually 
due to a combination of diverse anatomical and func-
tional factors that produce the collapse of the UA (3). 
The most common clinical manifestations are habitual 
snoring, mouth breathing, increased respiratory effort 
(2), night sweats, abnormal sleeping positions (such as 
hyperextension of the neck), restlessness, and nocturnal 
enuresis (3).
According to the American Academy of Pediatrics (4), 
polysomnography is the diagnostic method of choice 
for children, and it is accepted that an apnea-hypopnea 
index AHI (number of apnea and hypopnea events per 
hour of sleep) of between 1 and 3 constitutes the thres-
hold between normal and abnormal sleep (2,4).
The treatment of choice for children is adenotonsillec-
tomy (2,4) with 78% efficacy (3); nevertheless, it has not 
been shown that this resolves SAHS completely (5,6) 
and it is an invasive form of treatment for the child pa-
tient. The second option is continuous positive airway 
pressure (CPAP) (3,4). This palliative treatment causes 
discomfort and most patients do not become accustomed 
to it, which makes them uncooperative (5).
High prevalence of SAHS combined with a low rate of 
diagnosis and the serious impact on the quality of life of 
the child patient make it a health concern that the dentist 
should look out for in routine clinical practice. There is 
also a need to investigate new and more effective alter-
native therapies for treating this syndrome. In this con-
text, and in light of the apparently promising results ob-
tained in research, RME would appear to offer a SAHS 
treatment that is more effective and less invasive. 
The aim of this study was to conduct a systematic li-
terature review and meta-analysis to determine the 
effect of RME on SAHS and analyze its effects on the 
apnea-hypopnea index (AHI), oxygen saturation (SO2), 
sleep efficiency (SE), total sleep time (TST), percentage 
of rapid eye movement phase (REM) and arousal index 
(AI). 
Material and Methods  
This systematic literature review was conducted fo-
llowing PRISMA guidelines (Preferred Reporting Items 
for Systematic Reviews and Meta-Analyses) (7) and was 
registered in the PRISMA database (PROSPERO) (refe-
rence No. CRD42017037378).
-PICO question
The review set out to answer the following PICO (pa-
tient, intervention, comparison, outcome) question: In 
patients in growth with sleep apnea-hypopnea syndro-
me, does rapid maxillary expansion improve clinical 
variables or variables registered in polysomnography? 
-Inclusion and exclusion criteria 
Both “articles” and “articles in press” were included: 
randomized clinical trials, cohort studies, and case/
control studies (both retrospective and prospective). No 
restriction was placed on the publication date or the lan-
guage in which articles were published. Inclusion crite-
ria were: studies of patients in growth with SAHS who 
underwent RME, which registered oximetric values by 
means of polysomnography. Studies with patients sam-
ples <10 were excluded.
-Search strategy
Sources of information
To identify all studies of potential relevance, regardless 
of the language in which they were published, a rigorous 
electronic search was conducted in the PubMed, Scopus, 
Embase, and Cochrane databases. An electronic search 
was also conducted for grey literature in the Opengrey 
database. In some case, the authors were contacted by 
e-mail in order to request missing information. The search 
was completed manually, reviewing the bibliographies of 
the articles identified to locate further works that might 
have been missed in the initial search. The systematic re-
view and meta-analysis was conducted in October 2017. 
Search terms 
A list of search terms was formulated consisting of 
MeSH terms (Medical Subject Heading), as well as 
non-indexed terms that might identify relevant texts. 
Boolean operators (“OR” and “AND”) were used to 
link search terms (both MeSH/ and non indexed). Ba-
sed on the PICO question, the following search strategy 
was used: ((((((((((“Sleep Apnea, Obstructive”[Mesh]) 
OR “Sleep Apnea Syndromes”[Mesh]) OR “Snorin-
g”[Mesh]) OR “Sleep Disorders, Intrinsic”[Mesh]) OR 
Breathing) OR OSA) OR “respiration”[MeSH Terms])) 
AND ((((“disease”[MeSH Terms]) OR Disorders) OR 
“Palatal Expansion Technique”[Mesh]) OR “Child”[-
Mesh])) AND ((((“palatal expansion technique”[MeSH 
Terms]) OR Maxillary expansion) OR RME) OR Rapid 
maxillary expansion)) AND (((OSA improvement) OR 
sleep apnea syndrome healing) OR obstructive apnea 
improvement).
Study selection
Two independent reviewers (AMS-S and CB-A) syste-
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matically and independently assessed both the titles and 
the abstracts of the articles identified. In case of any di-
sagreement, a third reviewer was consulted (JMM-C). 
If an abstract failed to provide sufficient information 
to reach a decision, the full text was read before deci-
ding whether or not to include the article in analysis. 
Afterwards, the complete articles were read and the rea-
sons for excluding articles were registered. 
Study data
The following variables were registered for each article: 
author and year of publication, sample size, demogra-
phic variables (sex and mean age), type of study, pa-
tients lost during the study, AHI, SO2, SE, AI, TST, and 
percentage of REM phase sleep.  
-Quality assessment 
The quality of the studies was evaluated by the same 
researchers independently using the CONSORT quality 
criteria developed by Mattos et al. (8) for experimental 
studies. In cases of discrepancy between the two resear-
chers, consensus was reached and in case of any doubt, 
the third researcher was consulted.  
-Variables and synthesis of results 
Mean values and initial and final confidence intervals 
were registered for the following variables: AHI, SO2, 
SE, TST, percentage of REM, and AI. 
-Statistical analysis 
For quantitative synthesis, the differences between mean 
values were calculated and the confidence intervals (CI) 
between initial and final states. Heterogeneity was as-
sessed with the Q test and the I2 test. Heterogeneity 
was considered to exist when the Q test p-value was 
lower than 0.1. The combined random effects method 
was used to estimate mean differences. Publication bias 
was assessed by means of funnel plots and Rosenthal’s 
fail-safe number. Meta-analysis was performed using 
Comprehensive Meta-analysis Software V 3.0.
Results 
-Article selection process and flow diagram 
The initial electronic search identified 149 references 
related to changes produced in the upper airway after 
RME, of which 76 appeared in the Pubmed database, 45 
in Embase, 22 in Scopus and 6 in Cochrane; one article 
was located in grey literature. Forty-two articles were 
duplications leaving a total of 108. A further 75 were ex-
cluded after reading the titles and abstracts, as they were 
unrelated to the PICO question. A manual search was 
conducted among the bibliographies of the remaining 
33 articles, identifying four more works. After reading 
the complete text, 27 were eliminated for the following 
reasons: three investigated adults or young adults; in 
one the sample did not meet the SAHS criterion, one 
assayed maxillary advancement, one lacked tables 
(the author was contacted but no reply received), two 
investigated malformation syndromes, five used repea-
ted patient samples, one performed adenotonsillectomy 
simultaneously with RME, three because they did not 
provide sufficient study variable data, four did not carry 
out polysomnography, three were clinical case reports, 
two were literature reviews, and one was subject to an 
erratum and had been eliminated by PubMed.
Finally, 10 articles fulfilled the inclusion criteria and 
were included for qualitative analysis and nine for quan-
titative synthesis (meta-analysis), as one article was an 
observational study (9). The selection process is illustra-
ted as a PRISMA flow diagram (Fig. 1).
-Study characteristics 
The studies included for analysis all had samples of at 
least 10 patients. All indicated that the sample included 
patients with maxillary compression, and stated the pa-
tients’ mean age and sex. All patients were growing chil-
dren with an average age of around 8 years. 
Of the 10 studies, three had control groups, six had no 
control subjects and were not randomized, and one was 
an observational study (9) (and so excluded from quan-
titative analysis). With regard to the control groups, one 
group received no treatment (10), another control group 
underwent adenotonsillectomy (AT) (11), while in the 
remaining randomized study both groups underwent 
AM and RME but in different order (12). 
Most of the articles were of moderate quality according 
to CONSORT criteria modified by Mattos et al. (8) (Ta-
ble 1).
-Qualitative synthesis 
All studies observed improvements in apnea-hypopnea 
index (AHI) values after RME (10-15), with the excep-
tion of one work by Miano et al. (10). Guilleminault et 
al. (12) investigated the effect of performing adenoton-
sillectomy first or RME first in the treatment sequence, 
finding that after the first treatment phase (T1) AHI did 
not reach normal values – a residual component of the 
syndrome remained – although the improvement was 
statistically significant. At the end of the second phase 
(T2), having performed both AT surgery and RME, nor-
mal AHI values were obtained, regardless of the order in 
which the treatments wee applied. In the two works of 
better quality, a residual component also remained after 
treatment, which also disappeared after combined the-
rapy with AT and RME. Twelve years after RME, AHI 
remained stable and within the range of normality (9).
Oxygen saturation (S02) was measured in five studies, 
finding a significant decrease in hypoxia values in three 
of them (<92%), and reaching normal values after RME 
(14-16). But two works did not observe statistically 
significant changes in SO2 (10,11). Desaturation time 
(duration of saturation <92% within total sleep time) de-
creased and remained stable 12 years after treatment (9).
Sleep efficiency (SE) was measured in four works, ob-
tained by dividing total sleep time between the hours 
the child spent in bed and the real duration of reparative 
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Fig. 1: Flow diagram.
sleep. In three this was found to increase after treatment 
but without statistical significance (10,11,16). Miano 
et al. (10) did not find significant differences in SE be-
tween the group with SAHS and the control group either 
before or after treatment. Pirelli et al. found that sleep 
efficiency remained stable 12 years after treatment with 
RME (9).
Total sleep time (TST) was measured in four studies 
(10-12,16). Two obtained significant differences (11,12) 
with an increase in total hours of sleep after treatment. 
Guilleminault et al. found that patients slept for longer 
at the end of the first treatment phase (12), whether this 
was RME or AM, and continued to increase after the 
second phase, regardless of the order of treatment. Mia-
no et al. (10) found significant differences between the 
control group and SAHS patients before treatment, the 
control group sleeping longer, but did not find differen-
ces in the SAHS group before and after treatment. 
The percentage of rapid eye movement (REM) sleep 
was measured in three studies. In two, no significant di-
fferences were observed (10,16), and in the randomized 
case/control study by Guilleminault et al. (12) a signifi-
cant increase was obtained after both treatment phases 
(T1 and T2), regardless of the order of treatment (RME 
or AT performed first).  
The arousal index (AI) is the number of micro-awake-
nings divided by TST, which was measured in two 
studies. In Villa et al. (11) the AI did not decrease sig-
nificantly, while Miano et al. (10) found a significant 
difference between SAHS and control patients before 
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Table 1: Characteristics of studies analyzed and CONSORT quality criteria developed by Mattos et al., (2011).
treatment, but AI did not decrease significantly in the 
SAHS group as a result of treatment by RME.
Table 1 shows details of the studies selected, registering 
the type of study, sample size, losses, demographic va-
riables, oximetric variables (AHI, SO2, SE, TST, per-
centage of REM, and AI).  
-Quantitative synthesis 
Oximetric changes 
The apnea-hypopnea index (AHI) (Fig. 2) was registe-
red in all the studies selected and all found significant 
decreases as a result of treatment by RME. The random 
effects model obtained a difference in means of 5.79 
events/hour with a 95% CI (9.06 to 2.5) considered to 
present statistical significance (p<0.001), and showing 
high heterogeneity (I2> 75%) of 98.9% (Q=749.3; 
p=0.000).
With regard to oxygen saturation (SO2), minimum satu-
ration was measured in three of the studies (10,12,13), 
while the others registered mean oxygen saturation 
(10,11,14-16). The random effects models shown in Fi-
gure 2 estimate a difference in means of 6.7% with a 
95% CI (-2.7 to 16.1), which was not statistically signi-
ficant for minimum saturation, while for mean saturation 
an increase of 2.5% was obtained with a 95% CI (0.28 
to 4.80), which was statistically significant (p<0.027). 
Heterogeneity was high (I2> 75%) for both minimum 
oxygen saturation and mean saturation: I2=98.8% and 
I2=98% respectively.
-Sleep variables
Total sleep time (TST) showed a difference in means of 
29.2 minutes with a 95% CI (-5.29 to 63.7), which was not 
statistically significant (Fig. 3). For measurements of mi-
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Fig. 2: Apnea-Hypopnea Index (AHI), Minimum oxygen saturation and Mean oxygen saturation forest plots and funnel plots.
cro-awakenings of respiratory causes (arousal index, AI), 
a decrease of 2.17 events per hour with a 95% CI (-5.25 
to –0.58) showed statistical significance (p<0.001) (Fig. 
3). The percentage of REM phase sleep underwent sig-
nificant increases in all studies, with an increase in REM 
sleep of 1.2% after RME with a 95% CI (1.02 to 1.38) 
(p<0.001) (Fig. 3). Sleep efficiency (SE) underwent a di-
fference in mean values of 0.96% with a 95% CI (-1.57 to 
3.5) with statistical significance (Fig. 3).
Among all the sleep variables measured, TST presented 
the highest heterogeneity of results (I2= 84,9%), while 
the AI, REM and SE showed low heterogeneity (I2= 0%, 
I2=24.2%, I2= 0%, respectively).
-Publication bias 
In general, meta-analysis funnel plots (Figs. 2,3) show 
little symmetry between the studies analyzed, with most 
having small sample sizes and significant results; all pre-
sented possible publication bias. 
Classic fail-safe N for oximetric variables AHI and SO2 
were estimated, whereby 2,821 and 87 studies respec-
tively would be needed to counteract the results obtai-
ned in meta-analysis. This suggests that a considerable 
number of unpublished articles would be needed before 
the results of the present meta-analysis could be deemed 
insignificant.  
For sleep variables, the classic fail-safe N for REM per-
centage was 45. But for AI and SE, with classic fail-safe 
Ns of 2 and 0, only a few non-significant studies would 
be needed to alter meta-analysis results, making these 
variables highly exposed to publication bias. 
Discussion
Although surgical treatment of SAHS through the re-
moval of adenoids and tonsils (adenotonsillectomy) is 
considered the therapeutic option of choice, it has been 
noted that after this type of soft tissue surgery, some 
children continue to suffer respiratory problems (6). Gi-
ven the multi-factorial etiology of SAHS, this could be 
due to untreated skeletal disorders (17). This theory has 
been supported by Guillemiault et al. (18) and Tasker et 
al. (19), who observed that some children treated with 
adenotonsillectomy developed SAHS as adults, leading 
the authors to suspect some skeletal basis for SAHS. 
Moreover, Katz et al. (20) report an association between 
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Fig. 3: Total sleep time, Micro-awakenings of respiratory causes (Arousal Index), Percentage in REM phase sleep and Sleep efficiency forest 
plots and funnel plots.
maxillary compression and SAHS. For this reason RME 
could be an effective therapeutic option and studies such 
as Zhao et al. (21), using CBCT, have found that when 
maxillary compression is treated with RME, airway 
volume is enlarged in the nasal cavity and nasophary-
nx area (1) and the position of the tongue is improved 
contributing to increased space for the passage of air 
(1,21). So RME would appear to favor nasal respiration 
and could prevent airway obstruction (22). It has been 
shown that the outcomes of RME enjoy long-term sta-
bility (9,21). But a lack of space for the passage of air 
could also be due to oropharyngeal muscle hypotonia 
(22,23), and so research is underway into the efficacy of 
exercise-based coadjuvant therapies designed to achieve 
physiological respiration and to correct mouth breathing 
(23). Case/control studies would appear to indicate that 
myofunctional therapy reduces the residual symptoms 
remaining after adenotonsillectomy (23,12) and RME 
(12). Nevertheless, few studies have investigated this 
type of therapy, making it a line of research for future 
investigation. 
Doubt remains as to how beneficial RME can be for 
treating SAHS in children who do not present maxillary 
compression, given the risks that accompany this the-
rapy. In all the studies analyzed in the present literature 
review, all patients presented maxillary compression and 
it was for this reason that RME was applied. To date, no 
studies have been published on RME for treating SAHS 
in children without maxillary compression.  
Two previous similar meta-analyses have been publi-
shed (5,24) although the only variable analyzed was 
AHI. Both concluded that RME improved AHI values 
significantly, suggesting that RME is an effective treat-
ment for SAHS. But Machado-júnior et al., (24) in-
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cluded two studies with very similar samples in their 
meta-analysis (17,25), which could have weighted the 
qualitative synthesis, and so over-estimated the effect. 
To avoid this problem in the present meta-analysis, in 
three studies (13,17,25) analysis was only applied to one 
of the works, the one with the largest sample size (13), 
eliminating the other two to avoid any bias. The same 
problem occurred with samples in the studies Villa et al. 
(26) and Villa et al. (23), and so only the sample used in 
Villa et al. (23) was included for analysis, as this sample 
encompassed the sample used in Villa et al. (26), as ex-
plained in the latter article. 
In the present meta-analysis, the studies included for 
analysis were disparate and did not follow similar me-
thods or even the same treatment sequence, although 
they did analyze the same variables. Nevertheless, all 
the works obtained results that confirmed that RME is 
effective for treating SAHS in children (10,11,13,27). It 
would appear that RME improves nasal breathing (16), 
reduces nasal resistance, and mouth breathing disappea-
red in most of the children treated (22).
All the works obtained reductions in AHI to below 1, with 
the exception of two articles, but these works were found 
to be of poor quality (10, 12). Miano et al. (10) registered 
an AHI that was higher than the range of values obtained 
in most of the studies, suggesting that a residual SAHS 
component remained after treatment. Guilleminault et al. 
(12) failed to obtain any considerable improvement in 
AHI values after the first treatment phase (regardless of 
whether this was RME or AM surgery) but after comple-
ting combined therapy SAHS was eliminated completely. 
Villa et al. (11) argues that RME is a valid treatment op-
tion for children aged over 4 years with malocclusion and 
moderate SAHS, the age at which SAHS appears and its 
severity being the main factors influencing the choice of 
treatment. The authors confirmed that SAHS was resolved 
in most cases. Pirelli et al. (13) stressed that RME is a va-
lid treatment option providing the child does not present 
adenoidal and tonsil hypertrophy. Nevertheless, SAHS 
is produced by an interaction between the skeletal com-
ponent and soft tissue enlargement (12). In these cases, 
RME can act as a coadjuvant therapy after surgery (16). 
The work by Guilleminault et al. (12) appears to confirm 
this, obtaining an improvement in all signs and symptoms 
after applying RME and surgery in combination, regard-
less of the order in which they were carried out. They re-
port that in some cases the SAHS was resolved with the 
first treatment phase, although they do not propose any 
criteria to determine which treatment to apply first. In li-
ght of these findings, future research should set out to es-
tablish protocols to determine the predominant disorder in 
order to decide which treatment to apply first; thereafter, 
if the signs and symptoms do not disappear, an additional 
therapy can de applied. 
Lastly, RME could have an important role to play in 
preventative treatment of SAHS in children (22). Early 
diagnosis is important to prevent the consequences of 
the syndrome (1).
The present review suffered some limitations, in parti-
cular, the varying methods used in the articles analyzed, 
and the lack of high quality randomized case/control stu-
dies. In addition, as outlined above, some susceptibility 
to publication bias was detected. But in spite of these 
limitations, most of the works reviewed showed that 
RME would appear effective for treating slight or mo-
derate cases of SAHS in children, as most of the varia-
bles measured underwent significant improvements. The 
level of evidence was acceptable, although the review 
points to a need to establish measurement protocols that 
would allow clearer data comparison. 
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